^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Arenegyr (NGR-hTNF)

    i
    Associations
    News
    Trials
    Company:
    AGC Biologics
    Drug class:
    Vascular disrupting agent, Capillary permeability modulator, CD13 modulator
    Related drugs:
    Associations
    News
    Trials